- €11.67m
- €27.70m
- €6.90m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.58 | ||
| Price to Tang. Book | 0.58 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.33 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.25% | ||
| Return on Equity | -51.31% | ||
| Operating Margin | -156.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 6.86 | 12.91 | 7.23 | 5.45 | 6.9 | 4.9 | n/a | 11.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nicox SA is a France-based international ophthalmic company. It is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The Company has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). It has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.
Directors
- Michele Garufi CHM (67)
- Gavin Spencer EVP (51)
- Sandrine Gestin VPR (53)
- Emmanuelle Pierry GCN (52)
- Adrienne Graves NID
- Lester Kaplan NID (71)
- Jean-Francois Labbe NID (71)
- Lauren Silvernail NID (63)
- Luzi von Bidder NID (68)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 15th, 1996
- Public Since
- November 2nd, 1999
- No. of Employees
- 5
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Euronext - Paris- Shares in Issue
- 49,859,431
- Address
- Drakkar 2 - Batiment D, BIOT, 06410
- Web
- https://www.nicox.com
- Phone
- +33 497245300
- Auditors
- Ernst & Young
Upcoming Events for ALCOX
Q3 2025 Nicox SA Earnings Release
Half Year 2025 Nicox SA Earnings Release
Similar to ALCOX
AB Science SA
Euronext - Paris
Advicenne SA
Euronext - Paris
Aelis Farma SA
Euronext - Paris
Boiron SA
Euronext - Paris
DBV Technologies SA
Euronext - Paris
FAQ
What is the Nicox SA share price?
As of Today at 22:17 UTC, shares in Nicox SA are trading at €0.23. This share price information is delayed by 15 minutes.
How has the Nicox SA share price performed this year?
Shares in Nicox SA last closed at €0.23 and the price had moved by -34.04% over the past 365 days. In terms of relative price strength the Nicox SA share price has underperformed the FTSE Global All Cap Index by -35.69% over the past year.
What are the analyst and broker recommendations for Nicox SA?
The overall consensus recommendation for Nicox SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nicox SA dividend yield?
Nicox SA does not currently pay a dividend.
Does Nicox SA pay a dividend?
Nicox SA does not currently pay a dividend.
When does Nicox SA next pay dividends?
Nicox SA does not currently pay a dividend.
How do I buy Nicox SA shares?
To buy shares in Nicox SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nicox SA?
As of the previous close price of €0.23, shares in Nicox SA had a market capitalisation of €11.67m.
Where are Nicox SA shares listed?
Here are the trading details for Nicox SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALCOX
What kind of share is Nicox SA?
Based on an overall assessment of its quality, value and momentum Nicox SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nicox SA share price forecast for 2025?
The analyst consensus target price for shares in Nicox SA is €1.00. That is 327.35% above the last closing price of €0.23.
Analysts covering Nicox SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.25 for the next financial year.
Find out moreWhat is the trend in the Nicox SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nicox SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.97%.
As of the last closing price of €0.23, shares in Nicox SA were trading -5.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nicox SA PE Ratio?
The Nicox SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nicox SA?
Nicox SA's management team is headed by:
- Michele Garufi - CHM
- Gavin Spencer - EVP
- Sandrine Gestin - VPR
- Emmanuelle Pierry - GCN
- Adrienne Graves - NID
- Lester Kaplan - NID
- Jean-Francois Labbe - NID
- Lauren Silvernail - NID
- Luzi von Bidder - NID